AMRX logo

Amneal Pharmaceuticals, Inc. (AMRX) Gross profit

Annual gross profit:

$1.02B+$163.77M(+19.12%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMRX annual gross profit is $1.02 billion, with the most recent change of +$163.77 million (+19.12%) on December 31, 2024.
  • During the last 3 years, AMRX annual gross profit has risen by +$228.77 million (+28.90%).
  • AMRX annual gross profit is now at all-time high.

Performance

AMRX Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

quarterly gross profit:

$286.25M+$30.36M(+11.87%)
June 30, 2025

Summary

  • As of today (September 18, 2025), AMRX quarterly gross profit is $286.25 million, with the most recent change of +$30.36 million (+11.87%) on June 30, 2025.
  • Over the past year, AMRX quarterly gross profit has increased by +$36.31 million (+14.53%).
  • AMRX quarterly gross profit is now at all-time high.

Performance

AMRX quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM gross profit:

$1.07B+$36.31M(+3.50%)
June 30, 2025

Summary

  • As of today (September 18, 2025), AMRX TTM gross profit is $1.07 billion, with the most recent change of +$36.31 million (+3.50%) on June 30, 2025.
  • Over the past year, AMRX TTM gross profit has increased by +$128.11 million (+13.54%).
  • AMRX TTM gross profit is now at all-time high.

Performance

AMRX TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

AMRX Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.1%+14.5%+13.5%
3 y3 years+28.9%+39.2%+40.0%
5 y5 years+113.0%+97.4%+90.4%

AMRX Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+28.9%at high+60.6%at high+40.7%
5 y5-yearat high+113.0%at high+97.4%at high+90.4%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

AMRX Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$286.25M(+11.9%)
$1.07B(+3.5%)
Mar 2025
-
$255.89M(-2.7%)
$1.04B(+1.7%)
Dec 2024
$1.02B(+19.1%)
$262.87M(-2.5%)
$1.02B(+3.8%)
Sep 2024
-
$269.56M(+7.8%)
$983.49M(+3.9%)
Jun 2024
-
$249.95M(+5.0%)
$946.47M(+3.3%)
Mar 2024
-
$238.06M(+5.4%)
$916.54M(+7.0%)
Dec 2023
$856.66M(+7.6%)
$225.93M(-2.8%)
$856.66M(+0.6%)
Sep 2023
-
$232.53M(+5.7%)
$851.45M(+4.6%)
Jun 2023
-
$220.02M(+23.5%)
$813.82M(+1.8%)
Mar 2023
-
$178.19M(-19.3%)
$799.43M(+0.5%)
Dec 2022
$795.82M(+0.5%)
$220.71M(+13.2%)
$795.82M(+4.2%)
Sep 2022
-
$194.90M(-5.2%)
$763.51M(-0.6%)
Jun 2022
-
$205.63M(+17.8%)
$767.81M(-0.9%)
Mar 2022
-
$174.57M(-7.3%)
$774.67M(-2.1%)
Dec 2021
$791.66M(+19.4%)
$188.41M(-5.4%)
$791.66M(+2.8%)
Sep 2021
-
$199.20M(-6.3%)
$770.33M(+4.5%)
Jun 2021
-
$212.50M(+10.9%)
$737.08M(+10.1%)
Mar 2021
-
$191.56M(+14.7%)
$669.58M(+1.0%)
Dec 2020
$662.97M(+38.4%)
$167.07M(+0.7%)
$662.97M(+7.0%)
Sep 2020
-
$165.95M(+14.5%)
$619.86M(+9.8%)
Jun 2020
-
$145.00M(-21.6%)
$564.47M(+7.0%)
Mar 2020
-
$184.96M(+49.2%)
$527.74M(+10.1%)
Dec 2019
$479.16M(-33.9%)
$123.95M(+12.1%)
$479.16M(-12.9%)
Sep 2019
-
$110.57M(+2.1%)
$549.81M(-15.0%)
Jun 2019
-
$108.26M(-20.6%)
$647.15M(-9.8%)
Mar 2019
-
$136.38M(-29.9%)
$717.18M(-1.1%)
Dec 2018
$725.40M(+37.9%)
$194.61M(-6.4%)
$725.40M(+6.3%)
Sep 2018
-
$207.91M(+16.6%)
$682.21M(+12.0%)
Jun 2018
-
$178.29M(+23.3%)
$609.32M(+9.8%)
Mar 2018
-
$144.59M(-4.5%)
$554.76M(+35.3%)
Dec 2017
$526.18M(+44.3%)
$151.42M(+12.1%)
$410.16M(+25.0%)
Sep 2017
-
$135.01M(+9.1%)
$328.12M(+10.1%)
Jun 2017
-
$123.73M(>+9900.0%)
$298.04M(+19.8%)
Mar 2017
-
$0.00(-100.0%)
$248.79M(-29.5%)
Dec 2016
$364.63M(+3.5%)
-
-
Dec 2016
-
$69.38M(-33.9%)
$352.79M(-11.4%)
Sep 2016
-
$104.94M(+40.9%)
$398.18M(+2.3%)
Jun 2016
-
$74.48M(-28.4%)
$389.19M(-2.6%)
Mar 2016
-
$103.99M(-9.4%)
$399.56M(+12.6%)
Dec 2015
$352.40M(+11.7%)
$114.77M(+19.6%)
$354.80M(+17.9%)
Sep 2015
-
$95.95M(+13.1%)
$300.86M(+4.0%)
Jun 2015
-
$84.85M(+43.2%)
$289.34M(-7.9%)
Mar 2015
-
$59.23M(-2.6%)
$314.26M(-0.4%)
Dec 2014
$315.55M(+52.9%)
$60.82M(-28.0%)
$315.55M(+9.7%)
Sep 2014
-
$84.44M(-23.1%)
$287.65M(+8.6%)
Jun 2014
-
$109.77M(+81.4%)
$264.75M(+23.8%)
Mar 2014
-
$60.52M(+83.9%)
$213.87M(+1.3%)
Dec 2013
$206.34M(-27.0%)
$32.92M(-46.5%)
$211.22M(-12.9%)
Sep 2013
-
$61.54M(+4.5%)
$242.45M(-6.4%)
Jun 2013
-
$58.89M(+1.8%)
$258.94M(-6.8%)
Mar 2013
-
$57.87M(-9.8%)
$277.87M(-0.3%)
Dec 2012
$282.55M
$64.15M(-17.8%)
$278.83M(-4.5%)
Sep 2012
-
$78.03M(+0.3%)
$292.08M(+5.6%)
DateAnnualQuarterlyTTM
Jun 2012
-
$77.82M(+32.3%)
$276.71M(+7.0%)
Mar 2012
-
$58.83M(-24.0%)
$258.59M(+0.1%)
Dec 2011
$258.30M(-52.1%)
$77.40M(+23.5%)
$258.30M(+11.7%)
Sep 2011
-
$62.65M(+4.9%)
$231.34M(-29.8%)
Jun 2011
-
$59.70M(+2.0%)
$329.56M(-6.9%)
Mar 2011
-
$58.54M(+16.0%)
$354.04M(-34.3%)
Dec 2010
$539.26M(+186.7%)
$50.45M(-68.6%)
$539.26M(-6.4%)
Sep 2010
-
$160.87M(+91.1%)
$576.23M(+27.4%)
Jun 2010
-
$84.19M(-65.5%)
$452.25M(+13.3%)
Mar 2010
-
$243.76M(+178.9%)
$399.19M(+112.2%)
Dec 2009
$188.10M(+59.3%)
$87.41M(+136.9%)
$188.10M(+60.8%)
Sep 2009
-
$36.89M(+18.5%)
$116.97M(+23.7%)
Jun 2009
-
$31.13M(-4.7%)
$94.56M(-22.1%)
Mar 2009
-
$32.66M(+100.5%)
$121.39M(+5.3%)
Dec 2008
$118.10M(-28.9%)
$16.29M(+12.5%)
$115.28M(-13.4%)
Sep 2008
-
$14.48M(-75.0%)
$133.09M(-35.4%)
Jun 2008
-
$57.97M(+118.3%)
$206.04M(+15.1%)
Mar 2008
-
$26.55M(-22.1%)
$178.97M(+7.8%)
Dec 2007
$166.10M(+163.7%)
$34.09M(-61.0%)
$166.10M(+1.3%)
Sep 2007
-
$87.43M(+182.9%)
$163.94M(+80.1%)
Jun 2007
-
$30.90M(+125.9%)
$91.05M(+28.8%)
Mar 2007
-
$13.68M(-57.2%)
$70.69M(+12.2%)
Dec 2006
$63.00M(+16.7%)
$31.93M(+119.7%)
$63.00M(+102.8%)
Sep 2006
-
$14.54M(+37.9%)
$31.07M(+87.9%)
Jun 2006
-
$10.54M(+76.1%)
$16.53M(+176.1%)
Mar 2006
-
$5.99M(-54.3%)
$5.99M(-86.6%)
Dec 2005
$53.97M(+209.9%)
-
-
Sep 2004
-
$13.11M(+9.0%)
$44.64M(+27.4%)
Jun 2004
-
$12.03M(-24.8%)
$35.05M(+26.2%)
Mar 2004
-
$15.99M(+356.5%)
$27.77M(+84.5%)
Dec 2003
$17.41M(+189.1%)
$3.50M(-0.5%)
$15.05M(+17.6%)
Sep 2003
-
$3.52M(-25.8%)
$12.79M(+9.7%)
Jun 2003
-
$4.75M(+44.8%)
$11.66M(+44.4%)
Mar 2003
-
$3.28M(+162.7%)
$8.07M(+61.7%)
Dec 2002
$6.02M(-186.5%)
$1.25M(-47.7%)
$4.99M(+204.3%)
Sep 2002
-
$2.38M(+105.1%)
$1.64M(-171.3%)
Jun 2002
-
$1.16M(+490.4%)
-$2.30M(-56.5%)
Mar 2002
-
$197.00K(-109.4%)
-$5.29M(-24.0%)
Dec 2001
-$6.97M(+67.9%)
-$2.10M(+35.0%)
-$6.97M(-6.5%)
Sep 2001
-
-$1.56M(-14.8%)
-$7.45M(+3.7%)
Jun 2001
-
-$1.83M(+23.8%)
-$7.19M(+14.4%)
Mar 2001
-
-$1.48M(-43.0%)
-$6.29M(+14.3%)
Dec 2000
-$4.15M(-1417.5%)
-$2.59M(+100.1%)
-$5.50M(+89.0%)
Sep 2000
-
-$1.29M(+40.0%)
-$2.91M(+368.8%)
Jun 2000
-
-$925.00K(+33.9%)
-$621.00K(-176.8%)
Mar 2000
-
-$691.00K(<-9900.0%)
$809.00K(-59.4%)
Dec 1999
$315.00K(-212.5%)
$0.00(-100.0%)
$1.99M(0.0%)
Sep 1999
-
$995.00K(+97.0%)
$1.99M(+82.3%)
Jun 1999
-
$505.00K(+2.6%)
$1.09M(+114.3%)
Mar 1999
-
$492.00K(>+9900.0%)
$510.00K(-311.6%)
Dec 1998
-$280.00K
$0.00(-100.0%)
-$241.00K(0.0%)
Sep 1998
-
$96.00K(-223.1%)
-$241.00K(-28.5%)
Jun 1998
-
-$78.00K(-69.9%)
-$337.00K(+30.1%)
Mar 1998
-
-$259.00K
-$259.00K

FAQ

  • What is Amneal Pharmaceuticals, Inc. annual gross profit?
  • What is the all time high annual gross profit for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. annual gross profit year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. quarterly gross profit?
  • What is the all time high quarterly gross profit for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly gross profit year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. TTM gross profit?
  • What is the all time high TTM gross profit for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. TTM gross profit year-on-year change?

What is Amneal Pharmaceuticals, Inc. annual gross profit?

The current annual gross profit of AMRX is $1.02B

What is the all time high annual gross profit for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high annual gross profit is $1.02B

What is Amneal Pharmaceuticals, Inc. annual gross profit year-on-year change?

Over the past year, AMRX annual gross profit has changed by +$163.77M (+19.12%)

What is Amneal Pharmaceuticals, Inc. quarterly gross profit?

The current quarterly gross profit of AMRX is $286.25M

What is the all time high quarterly gross profit for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high quarterly gross profit is $286.25M

What is Amneal Pharmaceuticals, Inc. quarterly gross profit year-on-year change?

Over the past year, AMRX quarterly gross profit has changed by +$36.31M (+14.53%)

What is Amneal Pharmaceuticals, Inc. TTM gross profit?

The current TTM gross profit of AMRX is $1.07B

What is the all time high TTM gross profit for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high TTM gross profit is $1.07B

What is Amneal Pharmaceuticals, Inc. TTM gross profit year-on-year change?

Over the past year, AMRX TTM gross profit has changed by +$128.11M (+13.54%)
On this page